US outlines bold goals for bioeconomy
A new initiative to improve biotechnology and biomanufacturing capabilities and strengthen supply chains in the US has been launched by the
top of page
Shreeram Aradhye
to talk about Medical Affairs
and lorem ipsom et lorteum
Shreeram Aradhye
to talk about Medical Affairs
and lorem ipsom et lorteum
- Mar 14
- 1 min
Pfizer acquires Seagen in $43bn deal
Pfizer has acquired Seagen in a $43bn merger agreement, its largest purchase in a series of recent acquisitions, it was announced on Monday
- Feb 21
- 2 min
Spoonful of technology
GOLD highlights the top news stories in health technology solutions.
- Feb 9
- 1 min
Spotlight: December 2022–January 2023
GOLD looks back at some of the pharma industry’s recent news.
- Feb 6
- 2 min
Eli Lilly improves cold chain capacity
Eli Lilly has pledged over $1m to improve cold chain capacity for insulin in low- to middle-income countries.
- Jan 24
- 2 min
Fear for pharma growth prospects
Healthcare industry professionals are currently more sceptical of pharma's ability to grow compared to 2022, says new GlobalData report.
- Jan 17
- 1 min
Genomics identified as most impactful pharma trend
Genomics is the most impactful emerging trend in the pharma industry for 2023, according to GlobalData.
- Jan 17
- 1 min
Pharma voted second most trusted industry in Britain
The pharmaceutical industry is the second most trusted sector in Great Britain, according to the latest Ipsos Trustworthiness Index.
- Jan 13
- 1 min
Moderna becomes latest ABPI member
Moderna has become the latest member of the ABPI as part of its long-term commitment to expand in the UK.
- Jan 12
- 2 min
HBA names 2023 Woman of the Year
The HBA has named its 2023 Woman of the Year, Honourable Mentor and STAR volunteer leader.
- Jan 10
- 1 min
Potential blockbuster drug front runners highlighted
Some 15 treatments likely to achieve blockbuster status by 2027 have been highlighted in Clarivate's annual ‘Drugs to Watch' report.
- Jan 10
- 1 min
ROI in R&D declines sharply in 2022
Projected pharmaceutical R&D return on investment has hit its lowest level for 13 years, according to a new report by Deloitte.
- Jan 6
- 1 min
RSV drug nirsevimab chases FDA approval
A drug to treat infants with RSV is on its pathway to approval in the US following a successful Biologics License Application to the FDA.
- Dec 20, 2022
- 2 min
Spoonful of technology
Discover four recent technological advances delivering value for patients and improving health outcomes.
- Dec 13, 2022
- 1 min
Prescribing habits shift noted in IBD
Doctors treating IBD in the US are increasingly selecting biologic or small molecule therapies rather than traditional TNF inhibitors.
- Dec 9, 2022
- 1 min
A new moonshot for rare diseases
Rare diseases are gaining some well-deserved attention as a new R&D initiative was launched at the European Health Summit.
- Dec 6, 2022
- 1 min
Spotlight: October-November 2022
GOLD looks back at some of the pharma industry’s recent news.
- Nov 29, 2022
- 2 min
Landmark approval for first haemophilia B gene therapy
The first-ever gene therapy for the haemophilia B has been approved by the FDA, offering patients in the US a one-time therapy.
- Nov 29, 2022
- 1 min
Urgent need to boost trade for UK's life sciences, says ABPI
A new report on the current trade and investment position of the UK life sciences sector and supporting future growth highlights challenges.
- Nov 15, 2022
- 2 min
2022 Access to Medicine Index reveals improvement
Pharma companies have improved equitable access to their products, but more is needed, according to the 2022 Access to Medicine Index.
- Nov 15, 2022
- 2 min
Pharma's sustainability agenda centre stage in new ABPI report
Global action is required to ensure pharma's commitments to reach Net Zero are realised, according to a new ABPI report.
- Nov 9, 2022
- 1 min
First paediatric pneumococcal vaccine approved for 10 years
A new paediatric vaccine for pneumococcal disease has been approved by the UK's MHRA – the first-of-its-kind approval in 10 years.
- Nov 7, 2022
- 2 min
New climate action announced by pharma CEOs
To coincide with COP27, seven pharma CEOs have announced scalable action to collectively address emissions and impact climate change.
- Nov 7, 2022
- 1 min
Global health agencies collaborate to ease Ebola outbreak
CEPI, Gavi and WHO have announced a collective effort to support the Ugandan Government's response to the recent Ebolavirus outbreak.
- Nov 7, 2022
- 1 min
Thermo Fisher sponsorship supports future STEM workforce
Thermo Fisher Scientific named new title sponsor of a STEM competition in the US to engage young people and boost the future workforce.
- Nov 4, 2022
- 2 min
Spoonful of technology
What are some recent technologies to launch for patient and HCP benefit?
- Nov 2, 2022
- 2 min
Pfizer joins GSK in RSV success
Pfizer plans to file for approval for its RSV vaccine for infants by the end of 2022 after achieving positive Phase 3 results.
- Oct 31, 2022
- 2 min
WHO calls for urgent collaboration to end TB
The WHO has urged the global community to join forces to tackle TB after a new report shows signs of infection spreading.
- Oct 27, 2022
- 1 min
Renewed focus on measles and rubella in Senegal
The development of a new measles and rubella vaccine programme in Senegal is set to accelerate manufacturing and improve access.
- Oct 20, 2022
- 1 min
Germany pledges new funds to tackle antibiotic resistance
The Global Antibiotic Research & Development Partnership aims to bring five new treatments to market by 2025 with new funding from Germany.
- Oct 19, 2022
- 1 min
Spotlight: August-October 2022
GOLD looks back at the pharmaceutical industry’s top news stories from the past few months.
- Oct 13, 2022
- 1 min
First RSV vaccine for older adults earns pivotal Phase 3 results
A first-in-class vaccine for respiratory syncytial virus has shown to be highly efficacious in a Phase III trial, GSK has announced.
- Oct 13, 2022
- 1 min
Repurposing medicines toolkit launched
A toolkit to help navigate medicines repurposing has been launched by medical research charity LifeArc and the Medical Research Council.
- Oct 7, 2022
- 1 min
Promising outlook for integrating young talent in pharma
Collaboration between the pharmaceutical industry and academia is on the rise, according to a recent survey from the ABPI.
- Oct 7, 2022
- 1 min
Pfizer-BioNTech assemble with the Avengers in COVID booster drive
Pfizer and BioNTech collaborate with Marvel on a comic encouraging COVID-19 booster vaccinations in the US.
- Sep 29, 2022
- 2 min
Historic moment in Alzheimer’s drug development
Eisai and Biogen announce positive results from their Phase 3 trial of lecanemab, showing successful slowing of Alzheimer's progression.
- Sep 29, 2022
- 2 min
Pharma R&D set to increase despite energy crisis
The pharmaceutical sector expects to spend more on R&D in 2023 despite economic and political uncertainty, says new report from Ayming.
- Sep 27, 2022
- 1 min
Daiichi Sankyo in leukaemia treatment approval first
In a pharmaceutical industry first, Daiichi Sankyo has obtained Japanese approval for Ezharmia to treat blood cancer.
- Sep 27, 2022
- 1 min
Pfizer and Delix named HBA gender parity champions
Pfizer and Delix Therapeutics recognised as Global Champions of Greater Equity for Women in the Workplace by the HBA.
- Sep 27, 2022
- 1 min
Moderna joins BIA as 500th member
Moderna has joined the UK's BioIndustry Association, taking its membership to over 500 companies.
- Sep 21, 2022
- 1 min
GSK and Microsoft tackle Nepal disease transmission
A new disease surveillance project to curb the spread of pathogens, such as malaria, has been launched by GSK and Microsoft in Nepal.
- Sep 7, 2022
- 1 min
First malaria vaccine granted WHO prequalification
The WHO has granted the first prequalification for a malaria vaccine to GSK’s Mosquirix in an important step towards health equality.
- Aug 31, 2022
- 1 min
Roche makes moves in PCR technology
Roche has launched a powerful new digital PCR system to support the fight against cancer and other diseases.
- Aug 31, 2022
- 2 min
Spoonful of technology
What are some of the most recent technologies to launch in the pharmaceutical market?
- Aug 17, 2022
- 1 min
Spotlight: June-August 2022
What are the standout news stories in pharma over the past few months?
- Aug 11, 2022
- 2 min
Gilead fights monkeypox misinformation
In an effort to combat misinformation surrounding monkeypox, Gilead Sciences is partnering with LGBTQ+ and human rights organisations.
- Aug 4, 2022
- 1 min
French Biotech set to make waves in cell therapy evolution
French biotech startup Core Biogenesis has raised $10.5 million in Series A funding to further its cell therapy ambitions.
- Aug 4, 2022
- 1 min
Bayer in top spot for equality, diversity and inclusion
A new report on how pharmaceutical companies promote equality, diversity and inclusion in their organisations crowned Bayer as its winner.
- Jul 29, 2022
- 1 min
Access win for HIV patients in sub-Saharan Africa
The injectable HIV treatment cabotegravir is set to become more widely available in sub-Saharan Africa following a new licensing agreement.
- Jul 29, 2022
- 1 min
EC extends vaccine label to tackle monkeypox
An extension of the marketing authorisation for Bavarian Nordic’s smallpox vaccine, Imvanex has been granted by the European Commission.
bottom of page